blood cancer

How Viagra could boost a widely used blood cancer treatment
How Viagra could boost a widely used blood cancer treatment
Fierce Biotech
Viagra
Pfizer
stem cells
bone marrow
blood cancer
Sanofi
Mozobil
Flag link:
Led by BioNTech, six biotechs line up for October IPOs
Led by BioNTech, six biotechs line up for October IPOs
Endpoints
IPOs
MRNA
melanoma
inebilizumab
NMOSD
blood cancer
solid tumors
BioNTech
ADC Therapeutics
Viela Bio
Frequency Therapeutics
Aprea Therapeutics
Monopar Therapeutics
Flag link:
Deepening US footprint, AstraZeneca-partnered French biotech Innate shoots for $100M IPO
Deepening US footprint, AstraZeneca-partnered French biotech Innate shoots for $100M IPO
Endpoints
Innate Pharma
IPOs
AstraZeneca
blood cancer
solid tumors
Flag link:
RootPath Raises $7M to Bring Cancer Cell Therapy to Solid Tumors
RootPath Raises $7M to Bring Cancer Cell Therapy to Solid Tumors
Xconomy
RootPath
cell therapy
blood cancer
solid tumors
Flag link:
Pfizer, Exelixis cancer drugs get FDA approval for wider use
Pfizer, Exelixis cancer drugs get FDA approval for wider use
Reuters
Pfizer
Exelixis
Cabometyx
kidney cancer
Bosulif
blood cancer
Flag link:
FDA Accepts Genentech's Biologics License Application For Subcutaneous Formulation Of Rituximab
FDA Accepts Genentech's Biologics License Application For Subcutaneous Formulation Of Rituximab
Yahoo
FDA
Genentech
Halozyme
rituximab
blood cancer
Flag link:
Novartis' blood cancer drug bags a 'breakthrough' tag on the way to FDA filing
Novartis' blood cancer drug bags a 'breakthrough' tag on the way to FDA filing
Fierce Biotech
Novartis
blood cancer
breakthrough status
PKC412
FDA
Flag link:
FDA puts full clinical hold on CTI BioPharma's blood cancer drug
FDA puts full clinical hold on CTI BioPharma's blood cancer drug
Yahoo/Reuters
CTI BioPharma
FDA
blood cancer
pacritinib
Flag link:
Novartis braces for multibillion-dollar generics hit as Gleevec copies launch
Novartis braces for multibillion-dollar generics hit as Gleevec copies launch
Fierce Pharma
Novartis
generics
Gleevec
Sun Pharma
blood cancer
Flag link:
FDA gives full approval to Amgen blood cancer drug
FDA gives full approval to Amgen blood cancer drug
Yahoo/Reuters
FDA
Amgen
Kyprolis
blood cancer
Flag link:
Amgen's Imlygic May Not Boost Earnings But It Will Change Cancer Care
Amgen's Imlygic May Not Boost Earnings But It Will Change Cancer Care
Forbes
Amgen
Imlygic
T-Vec
blood cancer
Flag link:
Did Gilead Sciences Just Give Wall Street a Huge Head Fake?
Did Gilead Sciences Just Give Wall Street a Huge Head Fake?
Motley Fool
Gilead Sciences
Zydelig
blood cancer
Flag link:
Celgene and Agios Deliver Some Great "Bad" News
Celgene and Agios Deliver Some Great "Bad" News
Investopedia
Celgene
Agios
AG-348
AG-120
AG-221
blood cancer
Flag link:
FDA expands use of Imbruvica to treat rare form of blood cancer
FDA expands use of Imbruvica to treat rare form of blood cancer
Yahoo/Reuters
FDA
Imbruvica
JNJ
Pharmacyclics
blood cancer
Waldenstrom's Macroglobulinemia
Flag link:
Infinity Pharmaceuticals shares soar after AbbVie collaboration
Infinity Pharmaceuticals shares soar after AbbVie collaboration
Marketwatch
AbbVie
Infinity Pharmaceuticals
duvelisib
blood cancer
Flag link:
Infinity Pharma Snags Abbvie for Blood Cancer Drug Partnership
Infinity Pharma Snags Abbvie for Blood Cancer Drug Partnership
TheStreet.com
AbbVie
Infinity Pharmaceuticals
IPI-145
duvelisib
blood cancer
Flag link:
A Developing "Breakthrough" In Biotechnology that You Should Monitor
A Developing "Breakthrough" In Biotechnology that You Should Monitor
Motley Fool
Pharmacyclics
ibrutinib
blood cancer
JNJ
AbbVie
Flag link:
Gilead Sciences' Move Into Cancer Drugs
Gilead Sciences' Move Into Cancer Drugs
Seeking Alpha
Gilead
Pharmacyclics
blood cancer
leukemia
Flag link:
BDR Pharma seeks India license for Bristol-Myers drug
BDR Pharma seeks India license for Bristol-Myers drug
Reuters
BDR Pharma
India
Bristol-Myers Squibb
dasatinib
blood cancer
Flag link:
Pharmacyclics advances after reporting new data for blood cancer drug candidate ibrutinib
Pharmacyclics advances after reporting new data for blood cancer drug candidate ibrutinib
Yahoo/AP
blood cancer
Pharmacyclics
Flag link:

Pages